Evidence map›Paper›PMID 40177559›Full record

ArticleActa pharmaceutica Sinica. B2025

Synthesis and evaluation of TSPO-targeting radioligand [

Wenhui Fu, Qingyu Lin, Zhequan Fu, Tingting Yang, Dai Shi, Pengcheng Ma, Hongxing Su, Yunze Wang, Guobing Liu, Jing Ding and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenhui FuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Qingyu LinDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhequan FuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Tingting YangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Dai ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Pengcheng MaDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Hongxing SuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Yunze WangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Guobing LiuDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Jing DingDepartment of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Dengfeng ChengDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The translocator protein (TSPO) positron emission tomography (PET) can noninvasively detect neuroinflammation associated with epileptogenesis and epilepsy. This study explored the role of the TSPO-targeting radioligand [

Indexed as

EpilepsyFluorine-18NeuroimagingPETTSPO

Identifiers

PMID40177559
PMCPMC11959965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.